These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15277408)

  • 1. Circulating 1,5-anhydroglucitol levels in adult patients with diabetes reflect longitudinal changes of glycemia: a U.S. trial of the GlycoMark assay.
    McGill JB; Cole TG; Nowatzke W; Houghton S; Ammirati EB; Gautille T; Sarno MJ;
    Diabetes Care; 2004 Aug; 27(8):1859-65. PubMed ID: 15277408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL; Pyle L; Kelsey MM; Newnes L; Baumgartner A; Zeitler PS; Nadeau KJ
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy.
    Liu L; Wan X; Liu J; Huang Z; Cao X; Li Y
    Diabetes Technol Ther; 2012 Sep; 14(9):756-61. PubMed ID: 22731793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial differences in glycemic markers: a cross-sectional analysis of community-based data.
    Selvin E; Steffes MW; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL
    Ann Intern Med; 2011 Mar; 154(5):303-9. PubMed ID: 21357907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma.
    Paroni R; Ceriotti F; Galanello R; Battista Leoni G; Panico A; Scurati E; Paleari R; Chemello L; Quaino V; Scaldaferri L; Lapolla A; Mosca A
    Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can fructosamine be a surrogate for HbA(1c) in evaluating the achievement of therapeutic goals in diabetes?
    Narbonne H; Renacco E; Pradel V; Portugal H; Vialettes B
    Diabetes Metab; 2001 Nov; 27(5 Pt 1):598-603. PubMed ID: 11694860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No relationship between mean plasma glucose and glycated haemoglobin in patients with cystic fibrosis-related diabetes.
    Godbout A; Hammana I; Potvin S; Mainville D; Rakel A; Berthiaume Y; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):568-73. PubMed ID: 18922724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.
    Yamanouchi T; Ogata N; Tagaya T; Kawasaki T; Sekino N; Funato H; Akaoka L; Miyashita H
    Lancet; 1996 Jun; 347(9014):1514-8. PubMed ID: 8684103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of complementary markers in assessing glycaemic control in people with diabetic kidney disease undergoing iron or erythropoietin treatment.
    Konya J; Ng JM; Cox H; Cooke M; Lewis N; Bhandari S; Atkin SL; Kilpatrick ES
    Diabet Med; 2013 Oct; 30(10):1250-4. PubMed ID: 23758176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucose area under the profiles obtained with continuous glucose monitoring system relationships with HbA(lc) in pediatric type 1 diabetic patients.
    Salardi S; Zucchini S; Santoni R; Ragni L; Gualandi S; Cicognani A; Cacciari E
    Diabetes Care; 2002 Oct; 25(10):1840-4. PubMed ID: 12351488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of alternative markers of glycemia with hemoglobin A(1c) and fasting glucose.
    Juraschek SP; Steffes MW; Selvin E
    Clin Chem; 2012 Dec; 58(12):1648-55. PubMed ID: 23019309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum 1,5-anhydroglucitol and urinary excretion of N-acetylglucosaminidase and albumin determined at onset of NIDDM with 3-year follow-up.
    Yamanouchi T; Kawasaki T; Yoshimura T; Inoue T; Koshibu E; Ogata N; Funato H; Akaoka I; Miyashita H
    Diabetes Care; 1998 Apr; 21(4):619-24. PubMed ID: 9571353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
    Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
    Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES).
    Murata GH; Shah JH; Hoffman RM; Wendel CS; Adam KD; Solvas PA; Bokhari SU; Duckworth WC;
    Diabetes Care; 2003 Jun; 26(6):1759-63. PubMed ID: 12766106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nontraditional markers of glycemia: associations with microvascular conditions.
    Selvin E; Francis LM; Ballantyne CM; Hoogeveen RC; Coresh J; Brancati FL; Steffes MW
    Diabetes Care; 2011 Apr; 34(4):960-7. PubMed ID: 21335368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum 1,5-anhydroglucitol (Glycomark) levels in children with and without type 1 diabetes mellitus.
    Nguyen TM; Rodriguez LM; Mason KJ; Heptulla RA
    Pediatr Diabetes; 2007 Aug; 8(4):214-9. PubMed ID: 17659063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of serum 1,5 anhydroglucitol levels as a clinical test to differentiate subtypes of diabetes.
    Pal A; Farmer AJ; Dudley C; Selwood MP; Barrow BA; Klyne R; Grew JP; McCarthy MI; Gloyn AL; Owen KR
    Diabetes Care; 2010 Feb; 33(2):252-7. PubMed ID: 19933992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoglobin A(1c) and fructosamine for assessing glycemic control in diabetic patients with CKD stages 3 and 4.
    Chen HS; Wu TE; Lin HD; Jap TS; Hsiao LC; Lee SH; Lin SH
    Am J Kidney Dis; 2010 May; 55(5):867-74. PubMed ID: 20202728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.
    Dungan KM; Buse JB; Largay J; Kelly MM; Button EA; Kato S; Wittlin S
    Diabetes Care; 2006 Jun; 29(6):1214-9. PubMed ID: 16731998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lack of long-range negative correlations in glucose dynamics is associated with worse glucose control in patients with diabetes mellitus.
    Ogata H; Tokuyama K; Nagasaka S; Tsuchita T; Kusaka I; Ishibashi S; Suzuki H; Yamada N; Hamano K; Kiyono K; Struzik ZR; Yamamoto Y
    Metabolism; 2012 Jul; 61(7):1041-50. PubMed ID: 22304838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.